Apilimod mesylate by OrphAI Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval

Adare Phar­ma So­lu­tions di­vest­ed a busi­ness that man­u­fac­tures post­bi­ot­ic prod­ucts to dsm-fir­menich, a Dutch man­u­fac­tur­er that sells a range of prod­ucts, in­clud­ing nu­traceu­ti­cals and vi­t­a­mins.

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) Plen­ful, a start­up that … Sign up